Hydrophobic amino acid residues are critical for the immunodominant epitope of the goodpasture autoantigen - A molecular basis for the cryptic natureof the epitope
M. David et al., Hydrophobic amino acid residues are critical for the immunodominant epitope of the goodpasture autoantigen - A molecular basis for the cryptic natureof the epitope, J BIOL CHEM, 276(9), 2001, pp. 6370-6377
Goodpasture (GP) autoimmune disease is caused by autoantibodies to type IV
collagen that bind to the glomerular basement membrane, causing rapidly pro
gressing glomerulonephritis. The immunodominant GP(A) autoepitope is encomp
assed by residues 17-31 (the E-A region) within the noncollagenous (NC1) do
main of the alpha3(IV) chain. The GP epitope is cryptic in the NC1 hexamer
complex that occurs in the type IV collagen network found in tissues and in
accessible to autoantibodies unless the hexamer dissociates. In contrast, t
he epitope for the Mab3 monoclonal antibody is also located within the E-A
region, but is fully accessible in the hexamer complex. In this study, the
identity of residues that compose the GP(A) autoepitope was determined, and
the molecular basis of its cryptic nature was explored. This was achieved
using site-directed mutagenesis to exchange the alpha3(IV) residues in the
E-A region with the corresponding residues of the homologous but non-immuno
reactive alpha1(IV) NC1 domain and then comparing the reactivity of the mut
ated chimeras with GP(A) and Mab3 antibodies. It was shown that three hydro
phobic residues (Ala(18), Ile(19), and Val(27)) and Pro(28) are critical fo
r the GP(A) autoepitope, whereas two hydrophilic residues (Ser(21) and Ser(
31)) along with pro(28) are critical for the Mab3 epitope. These results su
ggest that the cryptic nature of the GP(A) autoepitope is the result of qua
ternary interactions of the alpha3, alpha4, and alpha5 NC1 domains of the h
examer complex that bury the one or more hydrophobic residues. These findin
gs provide critical information for understanding the etiology and pathogen
esis of the disease as well as for designing drugs that would mimic the epi
tope and thus block the binding of GP autoantibodies to autoantigen.